Clinical Trials Logo

Ant Sting clinical trials

View clinical trials related to Ant Sting.

Filter by:
  • None
  • Page 1

NCT ID: NCT03066986 Active, not recruiting - Immunotherapy Clinical Trials

Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)

Jumpvax
Start date: October 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the potential use of delta-inulin as an adjuvant to facilitate the desired immune response to Jack Jumper Ant (JJA) venom with a lower dose of venom, thus reducing adverse reactions, venom requirements and costs of treatment. Specifically we aim to compare outcomes of in-hospital JJA sting challenges and JJA venom specific IgE, and IgG4 responses to semi-rush JJA VIT at maintenance doses of 25 and 50 mcg of JJA venom, with and without delta-inulin adjuvant.